Patients With Severe Chronic Kidney Disease Being Evaluated With Nuclear Stress Testing of the Heart Using the Stress Agent Regadenoson

Nephrology
5
Pipeline Programs
1
Companies
1
Clinical Trials
4
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
5
Early DiscoveryClinical DevelopmentMarket

On Market (4)

Approved therapies currently available

U
PHYLLOCONTINApproved
aminophylline
Unknown Company
oral1979
U
SOMOPHYLLINApproved
aminophylline
Unknown Company
oral
U
SOMOPHYLLIN-DFApproved
aminophylline
Unknown Company
oral1980
U
TRUPHYLLINEApproved
aminophylline
Unknown Company
rectal1983

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Cook Medical
Cook MedicalIN - Bloomington
1 program
1
AminophyllinePhase 41 trial
Active Trials
NCT01336140CompletedEst. May 2012

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Cook MedicalAminophylline

Clinical Trials (1)

Attenuation of the Side Effect Profile of Regadenoson: Study With Aminophylline in Patients With Severe Kidney Disease Undergoing Myocardial Perfusion Imaging

Start: Jun 2011Est. completion: May 2012
Phase 4Completed

Related Jobs in Nephrology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space